Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S. Hamilton, Gerard M. McGeehan, Paula M. Krosky et al.|European Journal of Pharmacology|2014Cited by 29
Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1Colin M. Tice, David A. Claremon, Wei Zhao et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 12